A detailed history of Black Rock Inc. transactions in Absci Corp stock. As of the latest transaction made, Black Rock Inc. holds 5,344,812 shares of ABSI stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,344,812
Previous 899,626 494.11%
Holding current value
$16.8 Million
Previous $5.11 Million 222.22%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.92 - $6.58 $13 Million - $29.2 Million
4,445,186 Added 494.11%
5,344,812 $16.5 Million
Q1 2024

May 10, 2024

BUY
$3.41 - $5.74 $183,805 - $309,397
53,902 Added 6.37%
899,626 $5.11 Million
Q4 2023

Feb 13, 2024

SELL
$1.15 - $4.79 $473,895 - $1.97 Million
-412,083 Reduced 32.76%
845,724 $3.55 Million
Q3 2023

Nov 13, 2023

BUY
$1.28 - $2.41 $23,557 - $44,353
18,404 Added 1.48%
1,257,807 $1.66 Million
Q2 2023

Aug 11, 2023

SELL
$1.17 - $2.03 $3.17 Million - $5.51 Million
-2,713,460 Reduced 68.65%
1,239,403 $1.88 Million
Q1 2023

May 12, 2023

SELL
$1.58 - $3.41 $86,950 - $187,659
-55,032 Reduced 1.37%
3,952,863 $6.92 Million
Q4 2022

Feb 13, 2023

BUY
$2.0 - $3.58 $174,360 - $312,104
87,180 Added 2.22%
4,007,895 $8.42 Million
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $912,904 - $1.49 Million
309,459 Added 8.57%
3,920,715 $12.3 Million
Q2 2022

Aug 12, 2022

BUY
$3.13 - $8.83 $1.45 Million - $4.1 Million
464,569 Added 14.76%
3,611,256 $12 Million
Q1 2022

May 12, 2022

BUY
$5.87 - $9.46 $11.1 Million - $17.9 Million
1,889,129 Added 150.22%
3,146,687 $26.5 Million
Q4 2021

Feb 10, 2022

BUY
$7.88 - $18.03 $4.93 Million - $11.3 Million
625,975 Added 99.11%
1,257,558 $10.3 Million
Q3 2021

Nov 09, 2021

BUY
$10.37 - $30.29 $6.55 Million - $19.1 Million
631,583 New
631,583 $7.35 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $292M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.